Neuroscience
The Hospital of the University of Pennsylvania (HUP) has been recognized by The Joint Commission and the American Heart Association/American Stroke Association (AHA/ASA) as meeting The Joint Commission’s standards for Disease-Specific Care Comprehensive Stroke Center Certification, becoming the first center in Philadelphia and among a select few hospitals in the United States to be named as part of an elite group of providers focused on complex stroke care. Comprehensive Stroke Centers are recognized as industry leaders and are responsible for setting the national agenda in the highly-specialized field of stroke care.
“This accomplishment is truly a result of multidisciplinary and multi-departmental collaboration, as this new level of certification recognizes the significant resources in staff and training that comprehensive stroke centers must have to treat complex stroke,” said Scott Kasner, MD, director of the Penn Stroke Center at HUP and professor of neurology in the Perelman School of Medicine at the University of Pennsylvania. “The level of commitment to high quality care for this complex population was clearly evident to The Joint Commission’s survey team, and we are proud to offer superior care to stroke patients.”
HUP’s stroke center was founded in 1994 and designated as a Primary Stroke Center by the Joint Commission in 2004. In addition to this newly-achieved advanced Comprehensive Stroke Certification at HUP, Penn Medicine’s other hospitals – Pennsylvania Hospital and Penn Presbyterian Medical Center – received Primary Stroke Center certifications from The Joint Commission in the summer of 2012. This mix of Primary Stroke Centers and the advanced Comprehensive Stroke Center at HUP allows Penn Medicine to address the needs of the stroke patient population throughout the Philadelphia region.
Read the full story.
- Clinical Trials: Pradaxa (dabigatran Etexilate) And Stroke Prevention
From today's Guardian: Major drug trial highlights a new approach in stroke prevention The success of Pradaxa in a 44-country trial indicates a possible end to the use of the rat poison warfarin as a primary treatment to prevent stroke Press Association...
- Transient Ischemic Attack (tia)
From the BBC:Test 'identifies new stroke risk' Doctors have developed a simple checklist to show if patients who have had a mini-stroke are at immediate risk of a more serious attack. The Oxford University team, writing in the Lancet, said it...
- Stroke And Tissue Plasminogen Activator (tpa) Treatment
From The Globe and Mail: Stroke drug grossly underused, experts say The Globe and Mail 07 February 2005 [snip] TPA remains the sole drug approved for strokes. Yet only about 3 per cent of victims get it. Usually that's because they don't...
- Abstract Of The Day: Stroke And Cognition
VK Srikanth et al. Progressive dementia after first-ever stroke: A community-based follow-up study. Neurology 2004; 63:785-792. Address correspondence and reprint requests to Prof. Geoffrey A. Donnan, Director, National Stroke Research Institute, Neurosciences...
- Teaming Up For Neuroscience Innovation
Last Monday, following a briefing on the current state of neuroscience research across the United States, held in Philadelphia's University City Science Center and hosted by Congressman Chaka Fattah, we had the opportunity to take the morning's...
Neuroscience
HUP Becomes First Hospital in Philadelphia to Earn Joint Commission and AHA/ASA Certified Comprehensive Stroke Center Status
The Hospital of the University of Pennsylvania (HUP) has been recognized by The Joint Commission and the American Heart Association/American Stroke Association (AHA/ASA) as meeting The Joint Commission’s standards for Disease-Specific Care Comprehensive Stroke Center Certification, becoming the first center in Philadelphia and among a select few hospitals in the United States to be named as part of an elite group of providers focused on complex stroke care. Comprehensive Stroke Centers are recognized as industry leaders and are responsible for setting the national agenda in the highly-specialized field of stroke care.
“This accomplishment is truly a result of multidisciplinary and multi-departmental collaboration, as this new level of certification recognizes the significant resources in staff and training that comprehensive stroke centers must have to treat complex stroke,” said Scott Kasner, MD, director of the Penn Stroke Center at HUP and professor of neurology in the Perelman School of Medicine at the University of Pennsylvania. “The level of commitment to high quality care for this complex population was clearly evident to The Joint Commission’s survey team, and we are proud to offer superior care to stroke patients.”
HUP’s stroke center was founded in 1994 and designated as a Primary Stroke Center by the Joint Commission in 2004. In addition to this newly-achieved advanced Comprehensive Stroke Certification at HUP, Penn Medicine’s other hospitals – Pennsylvania Hospital and Penn Presbyterian Medical Center – received Primary Stroke Center certifications from The Joint Commission in the summer of 2012. This mix of Primary Stroke Centers and the advanced Comprehensive Stroke Center at HUP allows Penn Medicine to address the needs of the stroke patient population throughout the Philadelphia region.
Read the full story.
- Clinical Trials: Pradaxa (dabigatran Etexilate) And Stroke Prevention
From today's Guardian: Major drug trial highlights a new approach in stroke prevention The success of Pradaxa in a 44-country trial indicates a possible end to the use of the rat poison warfarin as a primary treatment to prevent stroke Press Association...
- Transient Ischemic Attack (tia)
From the BBC:Test 'identifies new stroke risk' Doctors have developed a simple checklist to show if patients who have had a mini-stroke are at immediate risk of a more serious attack. The Oxford University team, writing in the Lancet, said it...
- Stroke And Tissue Plasminogen Activator (tpa) Treatment
From The Globe and Mail: Stroke drug grossly underused, experts say The Globe and Mail 07 February 2005 [snip] TPA remains the sole drug approved for strokes. Yet only about 3 per cent of victims get it. Usually that's because they don't...
- Abstract Of The Day: Stroke And Cognition
VK Srikanth et al. Progressive dementia after first-ever stroke: A community-based follow-up study. Neurology 2004; 63:785-792. Address correspondence and reprint requests to Prof. Geoffrey A. Donnan, Director, National Stroke Research Institute, Neurosciences...
- Teaming Up For Neuroscience Innovation
Last Monday, following a briefing on the current state of neuroscience research across the United States, held in Philadelphia's University City Science Center and hosted by Congressman Chaka Fattah, we had the opportunity to take the morning's...